 | • レポートコード：20QY06-02485 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ドセタキセルのグローバル市場について種類別（20 mg/ml、40 mg/ml、60 mg/ml）、用途別（乳がん、前立腺がん、ノン小細胞肺がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ドセタキセル市場の概要 ・世界の主要地域別ドセタキセル市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のドセタキセル市場規模2015-2026：種類別（20 mg/ml、40 mg/ml、60 mg/ml） ・世界のドセタキセル市場規模2015-2026：用途別（乳がん、前立腺がん、ノン小細胞肺がん、その他） ・ドセタキセルの北米市場規模2015-2020 ・ドセタキセルのヨーロッパ市場規模2015-2020 ・ドセタキセルの中国市場規模2015-2020 ・ドセタキセルの日本市場規模2015-2020 ・ドセタキセルの東南アジア市場規模2015-2020 ・ドセタキセルのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Hengrui Medicine、Sanofi、Qilu Pharma、Shenzhen Main Luck Pharma、Jiangsu Aosaikang Pharma） ・ドセタキセルの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ドセタキセルの市場動向・機会・課題 ・調査の結論 |
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.
Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.
Market Analysis and Insights: Global Docetaxel Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Docetaxel market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Docetaxel industry.
Based on our recent survey, we have several different scenarios about the Docetaxel YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Docetaxel will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Docetaxel Scope and Market Size
The global Docetaxel market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Docetaxel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Docetaxel market is segmented into
20 mg/ml
40 mg/ml
60 mg/ml
Segment by Application, the Docetaxel market is segmented into
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Other
The Docetaxel market is analysed and market size information is provided by regions (countries). Segment by Application, the Docetaxel market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Docetaxel Market Share Analysis
Docetaxel market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Docetaxel business, the date to enter into the Docetaxel market, Docetaxel product introduction, recent developments, etc.
The major vendors covered:
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
…
1 Docetaxel Market Overview
1.1 Docetaxel Product Scope
1.2 Docetaxel Segment by Type
1.2.1 Global Docetaxel Sales by Type (2020-2026)
1.2.2 20 mg/ml
1.2.3 40 mg/ml
1.2.4 60 mg/ml
1.3 Docetaxel Segment by Application
1.3.1 Global Docetaxel Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Non-small Cell Lung Cancer
1.3.5 Other
1.4 Docetaxel Market Estimates and Forecasts (2015-2026)
1.4.1 Global Docetaxel Sales Growth Rate (2015-2026)
1.4.2 Global Docetaxel Revenue and Growth Rate (2015-2026)
1.4.3 Global Docetaxel Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Docetaxel Industry Impact
1.5.1 How the Covid-19 is Affecting the Docetaxel Industry
1.5.1.1 Docetaxel Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Docetaxel Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Docetaxel Players to Combat Covid-19 Impact
2 Docetaxel Estimate and Forecast by Region
2.1 Global Docetaxel Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Docetaxel Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Docetaxel Sales Market Share by Region (2015-2020)
2.2.2 Global Docetaxel Revenue Market Share by Region (2015-2020)
2.3 Global Docetaxel Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Docetaxel Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Docetaxel Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Docetaxel Estimates and Projections (2015-2026)
2.4.2 Europe Docetaxel Estimates and Projections (2015-2026)
2.4.3 China Docetaxel Estimates and Projections (2015-2026)
2.4.4 Japan Docetaxel Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Docetaxel Estimates and Projections (2015-2026)
2.4.6 India Docetaxel Estimates and Projections (2015-2026)
3 Global Docetaxel Competition Landscape by Players
3.1 Global Top Docetaxel Players by Sales (2015-2020)
3.2 Global Top Docetaxel Players by Revenue (2015-2020)
3.3 Global Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Docetaxel as of 2019)
3.4 Global Docetaxel Average Price by Company (2015-2020)
3.5 Manufacturers Docetaxel Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Docetaxel Players (Opinion Leaders)
4 Global Docetaxel Market Size by Type
4.1 Global Docetaxel Historic Market Review by Type (2015-2020)
4.1.1 Global Docetaxel Sales Market Share by Type (2015-2020)
4.1.2 Global Docetaxel Revenue Market Share by Type (2015-2020)
4.1.3 Global Docetaxel Price by Type (2014-2020)
4.2 Global Docetaxel Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Docetaxel Sales Forecast by Type (2021-2026)
4.2.2 Global Docetaxel Revenue Forecast by Type (2021-2026)
4.2.3 Global Docetaxel Price Forecast by Type (2021-2026)
5 Global Docetaxel Market Size by Application
5.1 Global Docetaxel Historic Market Review by Application (2015-2020)
5.1.1 Global Docetaxel Sales Market Share by Application (2015-2020)
5.1.2 Global Docetaxel Revenue Market Share by Application (2015-2020)
5.1.3 Global Docetaxel Price by Application (2015-2020)
5.2 Global Docetaxel Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Docetaxel Sales Forecast by Application (2021-2026)
5.2.2 Global Docetaxel Revenue Forecast by Application (2021-2026)
5.2.3 Global Docetaxel Price Forecast by Application (2021-2026)
3 North America Docetaxel Market Facts & Figures
3.2 North America Docetaxel Sales Market Share by Company (2015-2020)
3.3 North America Docetaxel Sales Market Share by Type (2015-2020)
3.4 North America Docetaxel Sales Market Share by Application (2015-2020)
4 Europe Docetaxel Market Facts & Figures
4.2 Europe Docetaxel Sales Market Share by Company (2015-2020)
4.3 Europe Docetaxel Sales Market Share by Type (2015-2020)
4.4 Europe Docetaxel Sales Market Share by Application (2015-2020)
5 China Docetaxel Market Facts & Figures
5.2 China Docetaxel Sales Market Share by Company (2015-2020)
5.3 China Docetaxel Sales Market Share by Type (2015-2020)
5.4 China Docetaxel Sales Market Share by Application (2015-2020)
6 Japan Docetaxel Market Facts & Figures
6.2 Japan Docetaxel Sales Market Share by Company (2015-2020)
6.3 Japan Docetaxel Sales Market Share by Type (2015-2020)
6.4 Japan Docetaxel Sales Market Share by Application (2015-2020)
7 Southeast Asia Docetaxel Market Facts & Figures
7.2 Southeast Asia Docetaxel Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Docetaxel Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Docetaxel Sales Market Share by Application (2015-2020)
8 India Docetaxel Market Facts & Figures
8.2 India Docetaxel Sales Market Share by Company (2015-2020)
8.3 India Docetaxel Sales Market Share by Type (2015-2020)
8.4 India Docetaxel Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Docetaxel Business
12.1 Hengrui Medicine
12.1.1 Hengrui Medicine Docetaxel Corporation Information
12.1.2 Hengrui Medicine Docetaxel Business Overview and Total Revenue
12.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hengrui Medicine Docetaxel Products Offered
12.1.5 Hengrui Medicine Recent Development
12.2 Sanofi
12.2.1 Sanofi Docetaxel Corporation Information
12.2.2 Sanofi Docetaxel Business Overview and Total Revenue
12.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Docetaxel Products Offered
12.2.5 Sanofi Recent Development
12.3 Qilu Pharma
12.3.1 Qilu Pharma Docetaxel Corporation Information
12.3.2 Qilu Pharma Docetaxel Business Overview and Total Revenue
12.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Qilu Pharma Docetaxel Products Offered
12.3.5 Qilu Pharma Recent Development
12.4 Shenzhen Main Luck Pharma
12.4.1 Shenzhen Main Luck Pharma Docetaxel Corporation Information
12.4.2 Shenzhen Main Luck Pharma Docetaxel Business Overview and Total Revenue
12.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Shenzhen Main Luck Pharma Docetaxel Products Offered
12.4.5 Shenzhen Main Luck Pharma Recent Development
12.5 Jiangsu Aosaikang Pharma
12.5.1 Jiangsu Aosaikang Pharma Docetaxel Corporation Information
12.5.2 Jiangsu Aosaikang Pharma Docetaxel Business Overview and Total Revenue
12.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jiangsu Aosaikang Pharma Docetaxel Products Offered
12.5.5 Jiangsu Aosaikang Pharma Recent Development
…
13 Docetaxel Manufacturing Cost Analysis
13.1 Docetaxel Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Docetaxel
13.4 Docetaxel Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Docetaxel Distributors List
14.3 Docetaxel Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Docetaxel Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Docetaxel Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Docetaxel Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Docetaxel Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Docetaxel Players to Combat Covid-19 Impact
Table 8. Global Market Docetaxel Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Docetaxel Sales (K Units) by Region (2015-2020)
Table 10. Global Docetaxel Sales Market Share by Region (2015-2020)
Table 11. Global Docetaxel Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Docetaxel Revenue Share by Region (2015-2020)
Table 13. Global Docetaxel Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Docetaxel Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Docetaxel Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Docetaxel Revenue Share Forecast by Region (2021-2026)
Table 17. Global Docetaxel (K Units) of Key Companies (2015-2020)
Table 18. Global Docetaxel Sales Share by Company (2015-2020)
Table 19. Global Docetaxel Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Docetaxel Revenue Share by Company (2015-2020)
Table 21. Global Docetaxel by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Docetaxel as of 2019)
Table 22. Global Docetaxel Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Docetaxel Manufacturing Sites and Area Served
Table 24. Manufacturers Docetaxel Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Docetaxel Players
Table 27. Global Docetaxel Sales (K Units) by Type (2015-2020)
Table 28. Global Docetaxel Sales Share by Type (2015-2020)
Table 29. Global Docetaxel Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Docetaxel Price (K Units) by Type (2015-2020)
Table 31. Global Docetaxel Sales Share by Type (2021-2026)
Table 32. Global Docetaxel Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Docetaxel Revenue Share by Type (2021-2026)
Table 34. Global Docetaxel Price (K Units) by Type (2021-2026)
Table 35. Global Docetaxel Sales (K Units) by Application (2015-2020)
Table 36. Global Docetaxel Sales Share by Application (2015-2020)
Table 37. Global Docetaxel Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Docetaxel Price (K Units) by Application (2015-2020)
Table 39. Global Docetaxel Sales (K Units) by Application (2021-2026)
Table 40. Global Docetaxel Sales Share by Application (2021-2026)
Table 41. Global Docetaxel Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Docetaxel Revenue Share by Application (2021-2026)
Table 43. Global Docetaxel Price (K Units) by Application (2021-2026)
Table 44. United States Docetaxel Sales (K Units) by Company (2015-2020)
Table 45. United States Docetaxel Sales Market Share by Company (2015-2020)
Table 46. United States Docetaxel Sales (K Units) by Type (2015-2020)
Table 47. United States Docetaxel Sales Market Share by Type (2015-2020)
Table 48. United States Docetaxel Sales (K Units) by Application (2015-2020)
Table 49. United States Docetaxel Sales Market Share by Application (2015-2020)
Table 50. Europe Docetaxel Sales (K Units) by Company (2015-2020)
Table 51. Europe Docetaxel Sales Market Share by Company (2015-2020)
Table 52. Europe Docetaxel Sales (K Units) by Type (2015-2020)
Table 53. Europe Docetaxel Sales Market Share by Type (2015-2020)
Table 54. Europe Docetaxel Sales (K Units) by Application (2015-2020)
Table 55. Europe Docetaxel Sales Market Share by Type (2015-2020)
Table 56. China Docetaxel Sales (K Units) by Company (2015-2020)
Table 57. China Docetaxel Sales Market Share by Company (2015-2020)
Table 58. China Docetaxel Sales (K Units) by Type (2015-2020)
Table 59. China Docetaxel Sales Market Share by Type (2015-2020)
Table 60. China Docetaxel Sales (K Units) by Application (2015-2020)
Table 61. China Docetaxel Sales Market Share by Application (2015-2020)
Table 62. Japan Docetaxel Sales (K Units) by Company (2015-2020)
Table 63. Japan Docetaxel Sales Market Share by Company (2015-2020)
Table 64. Japan Docetaxel Sales (K Units) by Type (2015-2020)
Table 65. Japan Docetaxel Sales Market Share by Type (2015-2020)
Table 66. Japan Docetaxel Sales (K Units) by Application (2015-2020)
Table 67. Japan Docetaxel Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Docetaxel Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Docetaxel Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Docetaxel Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Docetaxel Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Docetaxel Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Docetaxel Sales Market Share by Application (2015-2020)
Table 74. India Docetaxel Sales (K Units) by Company (2015-2020)
Table 75. India Docetaxel Sales Market Share by Company (2015-2020)
Table 76. India Docetaxel Sales (K Units) by Type (2015-2020)
Table 77. India Docetaxel Sales Market Share by Type (2015-2020)
Table 78. India Docetaxel Sales (K Units) by Application (2015-2020)
Table 79. India Docetaxel Sales Market Share by Application (2015-2020)
Table 80. Hengrui Medicine Corporation Information
Table 81. Hengrui Medicine Description and Business Overview
Table 82. Hengrui Medicine Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Hengrui Medicine Docetaxel Product
Table 84. Hengrui Medicine Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Docetaxel Product
Table 89. Sanofi Recent Development
Table 90. Qilu Pharma Corporation Information
Table 91. Qilu Pharma Description and Business Overview
Table 92. Qilu Pharma Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Qilu Pharma Docetaxel Product
Table 94. Qilu Pharma Recent Development
Table 95. Shenzhen Main Luck Pharma Corporation Information
Table 96. Shenzhen Main Luck Pharma Description and Business Overview
Table 97. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Shenzhen Main Luck Pharma Docetaxel Product
Table 99. Shenzhen Main Luck Pharma Recent Development
Table . Jiangsu Aosaikang Pharma Corporation Information
Table . Jiangsu Aosaikang Pharma Description and Business Overview
Table . Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Jiangsu Aosaikang Pharma Docetaxel Product
Table . Jiangsu Aosaikang Pharma Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Docetaxel Distributors List
Table 108. Docetaxel Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Docetaxel Product Picture
Figure 2. Global Docetaxel Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Docetaxel Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Examples
Figure 7. Prostate Cancer Examples
Figure 8. Non-small Cell Lung Cancer Examples
Figure 9. Other Examples
Figure 10. Global Docetaxel Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Docetaxel Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Docetaxel Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Docetaxel Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Docetaxel Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Docetaxel Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Docetaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Docetaxel Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Docetaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Docetaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Docetaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Docetaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Docetaxel Players Market Share by Revenue in Docetaxel 2015 & 2019
Figure 28. Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Docetaxel Revenue Share by Type (2015-2020)
Figure 30. Global Docetaxel Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Docetaxel Revenue Share by Application (2015-2020)
Figure 32. Global Docetaxel Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Docetaxel Sales Market Share by Type in 2019
Figure 34. United States Docetaxel Sales Market Share by Type in 2019
Figure 35. Europe Docetaxel Sales Market Share by Company in 2019
Figure 36. Europe Docetaxel Sales Market Share by Type in 2019
Figure 37. Europe Docetaxel Sales Market Share by Application in 2019
Figure 38. China Docetaxel Sales Market Share by Company in 2019
Figure 39. China Docetaxel Sales Market Share by Type in 2019
Figure 40. China Docetaxel Sales Market Share by Application in 2019
Figure 41. Japan Docetaxel Sales Market Share by Company in 2019
Figure 42. Japan Docetaxel Sales Market Share by Type in 2019
Figure 43. Japan Docetaxel Sales Market Share by Application in 2019
Figure 44. Southeast Asia Docetaxel Sales Market Share by Company in 2019
Figure 45. Southeast Asia Docetaxel Sales Market Share by Type in 2019
Figure 46. Southeast Asia Docetaxel Sales Market Share by Application in 2019
Figure 47. India Docetaxel Sales Market Share by Company in 2019
Figure 48. India Docetaxel Sales Market Share by Type in 2019
Figure 49. India Docetaxel Sales Market Share by Application in 2019
Figure 50. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Shenzhen Main Luck Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Jiangsu Aosaikang Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Docetaxel
Figure 57. Manufacturing Process Analysis of Docetaxel
Figure 58. Docetaxel Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
ドセタキセル三水和物の世界市場レポート2020 Market Analysis and Insights: Global Docetaxel Trihydrate (CAS 148408-66-6) Market The global Docetaxel Trihydrate (CAS 148408-66-6) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Docetaxel Trihydrate (C…- ドセタキセル三水和物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Docetaxel Trihydrate (CAS 148408-66-6) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Doceta…
- 樹状細胞および腫瘍細胞がんワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…
- 肺がん診断及び治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lung Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lung C…
- 癌用バイオマーカーの世界市場レポート2020 Market Analysis and Insights: Global Cancer Biomarkers Market The global Cancer Biomarkers market was valued at US$ 11710 million in 2019 and will reach US$ 18790 million by the end of 2026, growing at a CAGR of 6.9% during 2020-2026. Global Cancer Biomarkers Scope and Market Size The global Cancer …